Cargando…
Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain
Migraine and neuropathic pain (NP) are both painful, disabling, chronic conditions which exhibit some symptom similarities and are thus considered to share a common etiology. The calcitonin gene-related peptide (CGRP) has gained credit as a target for migraine management; nevertheless, the efficacy...
Autores principales: | Tajti, János, Szok, Délia, Csáti, Anett, Szabó, Ágnes, Tanaka, Masaru, Vécsei, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959352/ https://www.ncbi.nlm.nih.gov/pubmed/36835524 http://dx.doi.org/10.3390/ijms24044114 |
Ejemplares similares
-
Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review
por: Szok, Délia, et al.
Publicado: (2023) -
Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
por: Szok, Délia, et al.
Publicado: (2015) -
Therapeutic Approaches for Peripheral and Central Neuropathic Pain
por: Szok, Délia, et al.
Publicado: (2019) -
From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment
por: Tanaka, Masaru, et al.
Publicado: (2023) -
Interictal brain activity differs in migraine with and without aura: resting state fMRI study
por: Faragó, Péter, et al.
Publicado: (2017)